Clinical Enzyme Tests

• 

  Subject Areas on Research

  • A sensitivity analysis of enzymatic estimation of infarct size. 
  • A word of caution in the use of neuron-specific enolase expression in tumor diagnosis. 
  • Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids. 
  • Acute myocardial infarction. 
  • An overview of the laboratory diagnosis of lead poisoning. 
  • Cardiac isoenzymes following heart transplantation. 
  • Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). 
  • Chloroacetate esterase positivity in acute lymphoblastic leukemia. 
  • Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. 
  • Correlation of mucosal disaccharidase activities with histology in evaluation of rejection following intestinal transplantation. 
  • Diagnosis and treatment of acute coronary ischemic syndromes: a update for 1995. 
  • Diagnosis of acute myocardial infarction in a community hospital: significance of CPK-MB determination. 
  • Diagnosis, incidence, and clinical significance of early postoperative ischemia after transmyocardial laser revascularization. 
  • Diagnostic problem in acute myocardial infarction: CK-MB in the absence of abnormally elevated total creatine kinase levels. 
  • Digital microfluidic platform for multiplexing enzyme assays: implications for lysosomal storage disease screening in newborns. 
  • ELECTROPHORETIC SEPARATION OF HYDROLYTIC ENZYMES OF THE FEMALE RAT REPRODUCTIVE TRACT. 
  • Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. 
  • Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation. 
  • Elevated skeletal muscle creatine kinase MB isoenzyme levels in marathon runners. 
  • Evaluation of myocardial viability by MRI. 
  • Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis. 
  • Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease. 
  • Helicobacter pylori-like microorganisms and chronic active gastritis in ferrets. 
  • Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. 
  • Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve. 
  • Intraoperative detection of myocardial damage during coronary artery surgery by plasma creatine phosphokinase isoenzyme analysis. 
  • Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? 
  • Jaundice. Value of five-day steroid test in differential diagnosis. 
  • Late appearance of skin rash and abnormal serum enzymes in Rocky Mountain spotted fever. A case report. 
  • Mediastinal pancreatic pseudocysts in children. 
  • Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy. 
  • Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial. 
  • Newborn screening for lysosomal storage disorders. 
  • Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction. 
  • Optimal use of serum enzyme levels in the diagnosis of acute myocardial infarction. The perspective in 1980. 
  • Plasma dopamine-beta-hydroxylase in the diagnosis of neuroblastoma. 
  • Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort. 
  • QRS scoring and anterior and inferior MI size. 
  • Quantitative influence of serum creatine kinase isoenzyme MB estimated infarct size and other prognostic variables on one year mortality after acute myocardial infarction. 
  • Recognition of postoperative acute myocardial infarction. Application of isoenzyme techniques. 
  • Rectal mucosal ornithine decarboxylase activity is not a useful marker of risk for colorectal neoplasia. 
  • Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. 
  • Renal vein renins: inability to predict response to revascularization in patients with hypertension. 
  • Serum angiotensin converting enzyme activity in evaluation of patients with liver disease. 
  • Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. 
  • The chlorinated AHR ligand 3,3',4,4',5-pentachlorobiphenyl (PCB126) promotes reactive oxygen species (ROS) production during embryonic development in the killifish (Fundulus heteroclitus). 
  • The diagnosis of acute myocardial infarction. 
  • The importance of identification of the myocardial-specific isoenzyme of creatine phosphokinase (MB form) in the diagnosis of acute myocardial infarction. 
  • The management of acute coronary insufficiency. 
  • The radiologic evaluation of the patient with suspected pulmonary thromboembolic disease. 
  • The relationship between enzymatic and histologic estimates of the extent of myocardial infarction in conscious dogs with permanent coronary occlusion. 
  • The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease. 
  • The use of histidase for the study of amniotic cell origin and histidinemia. 
  • Usefulness of combining necrosis and platelet markers in triaging patients presenting with chest pain to the emergency department. 
  • [THE ENZYMES OF THE LEUKOCYTE]. 
  • gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C.